Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

Cited by (423)

Items 101–200 of 423

1. Human Neurobiological Approaches to Hedonically Motivated Behaviors
   Kyle Stanley Burger, Grace Elisabeth Shearrer, Jennifer R. Sadler · 2020 · Cambridge University Press eBooks
2. Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools
   Mark Damian Griffiths · 2020 · Cambridge University Press eBooks
3. Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
   José L. Juárez‐Morales, Claus J. Schulte, Sofia A. Pezoa, Grace K. Vallejo, William C. Hilinski, Samantha J. England, Sarah de Jager, Katharine E. Lewis · 2016 · Neural Development
4. Pharmacological Augmentations of SRIs for Obsessive Compulsive Disorder
   Eric W. Leppink, Jon Edgar Grant · 2017 · Wiley eBooks
5. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis
   Dongdong Zhou, Xiaoxin Zhou, Yao Li, Kai-Fu Zhang, Zhen Lv, Xiaorong Chen, Li-Yang Wan, Wo Wang, Gao-Mao Wang, Daqi Li et al. · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
6. Invasive and Non-invasive Neurostimulation for OCD
   Isidoor O. Bergfeld, Eva Dijkstra, Ilse Graat, Pelle P. de Koning, Bastijn J.G. van den Boom, Tara Arbab, Nienke C C Vulink, Damiaan A J P Denys, Ingo Willuhn, Roel J. T. Mocking · 2021 · Current topics in behavioral neurosciences
7. Brain Gamma-Aminobutyric Acid (GABA) Concentration of the Prefrontal Lobe in Unmedicated Patients with Obsessive-Compulsive Disorder: A Research of Magnetic Resonance Spectroscopy.
   Zongfeng Zhang, Qing Fan, Yanle Bai, Zhen Wang, Haiyin Zhang, Zeping Xiao · 2016 · Europe PMC (PubMed Central)
8. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap
   Henry Szechtman, Brian Herbert Harvey, Erik Z. Woody, Kurt Leroy Hoffman · 2019 · Pharmacological Reviews
9. Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder
   Ria Gupta, Sidharth Mehan, Pranshul Sethi, Aradhana Prajapati, Abdulrahman Alshammari, Metab Alharbi, Haneen A. Al‐Mazroua, Acharan Singh Narula · 2022 · Brain Sciences
10. Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder
    Porton, B, Greenberg, B D, Askland, K, Serra, L M, Gesmonde, J, Rudnick, G, Rasmussen, S A, Kao, H-T · 2013 · Translational Psychiatry
11. Cingulate and thalamic metabolites in obsessive-compulsive disorder
    Joseph O’Neill, Tsz M. Lai, Courtney L. Sheen, Giulia C. Salgari, Ronald Ly, Casey C. Armstrong, Susanna W. Chang, Jennifer G. Levitt, Noriko Salamon, Jeffry R. Alger et al. · 2016 · Psychiatry Research Neuroimaging
12. Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions
    Christopher Pittenger · 2017 · Handbook of experimental pharmacology
13. Transcranial magnetic stimulation of the medial prefrontal cortex for psychiatric disorders: a systematic review
    Rodrigo C. Marques, Larissa Vieira, Déborah Marques, Amaury Cantilino · 2019 · Brazilian Journal of Psychiatry
14. Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis
    Hadi, Fatemeh, Kashefinejad, Shayan, Kamalzadeh, Leila, Hoobehfekr, Saba, Shalbafan, Mohammadreza · 2021 · BMC Pharmacology and Toxicology
15. The Role of Serotonin in Orbitofrontal Function and Obsessive-Compulsive Disorder
    Maia, Tiago V., Cano-Colino, Maria · 2015 · Clinical Psychological Science
16. Glutamate Modulators in the Treatment of Obsessive-Compulsive Disorder
    Christopher Pittenger · 2015 · Psychiatric Annals
17. "Hyperglutamatergic cortico-striato-thalamo-cortical circuit" breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome
    Eric J. Nordstrom, Katie C. Bittner, Michael J. McGrath, Clinton R. Parks, Frank H. Burton · 2015 · Brain Research
18. Can Neuroimaging Provide Reliable Biomarkers for Obsessive-Compulsive Disorder? A Narrative Review
    Ilana Frydman, Juliana Braga de Salles Andrade, Paula Vigne, Leonardo Franklin Fontenelle · 2016 · Current Psychiatry Reports
19. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
    Mohammadrasoul Khalkhali, Setareh Aram, Homa Zarrabi, Moosa Kafie, Abtin Heidarzadeh · 2016 · PubMed Central
20. Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial
    Mohammadreza Shalbafan, Farzaneh Malekpour, Borna Tadayon Najafabadi, Kiandokht Ghamari, Seyed Ali Dastgheib, Arash Mowla, Elham Shirazi, Mehrdad Eftekhar Ardebili, Maryam Ghazizadeh‐Hashemi, Shahin Akhondzadeh · 2019 · Journal of Psychopharmacology
21. Could Dietary Glutamate Play a Role in Psychiatric Distress?
    A. Zarina Kraal, Nicole R. Arvanitis, Andrew P. Jaeger, Vicki L. Ellingrod · 2019 · Neuropsychobiology
22. Anterior cingulate cortex glutamate and its association with striatal functioning during cognitive control
    Jilly Naaijen, David J. Lythgoe, Marcel P. Zwiers, Catharina Annette Hartman, Pieter J. Hoekstra, Jan K. Buitelaar, Esther Aarts · 2018 · European Neuropsychopharmacology
23. Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence
    José Paulo Couto, Ricardo Moreira · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
24. An MRI Study of the Metabolic and Structural Abnormalities in Obsessive-Compulsive Disorder
    Juliana Braga de Salles Andrade, Fernanda Meireles Ferreira, Chao Suo, Murat Yücel, Ilana Frydman, Marina Monteiro, Paula Vigne, Leonardo Franklin Fontenelle, Fernanda Freire Tovar-Moll · 2019 · Frontiers in Human Neuroscience
25. Glutamate Genetics in Obsessive-Compulsive Disorder: A Review.
    Rageen Rajendram, Sefi Kronenberg, Christie L. Burton, Paul Daniel Arnold · 2017 · Europe PMC (PubMed Central)
26. Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report
    Benjamin Kelmendi, Stephen A. Kichuk, Giuliana DePalmer, Gayle K. Maloney, Terence H. W. Ching, Alexander Belser, Christopher Pittenger · 2022 · Heliyon
27. Timing matters: using optogenetics to chronically manipulate neural circuitry and rhythms
    Michelle M. Sidor, Colleen A. McClung · 2014 · Frontiers in Behavioral Neuroscience
28. Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression
    Benjamin Fredrick Gruenbaum, Ruslan Kutz, Alexander Anatolievich Zlotnik, Matthew Boyko · 2020 · Therapeutic Advances in Psychopharmacology
29. A Systematic Review of Genomic Regions and Candidate Genes Underlying Behavioral Traits in Farmed Mammals and Their Link with Human Disorders
    Amanda Botelho Alvarenga, Hinayah Rojas de Oliveira, Shiyi Chen, Stephen Paul Miller, Jeremy N. Marchant, Laís Grigoletto, Luiz F. Brito · 2021 · Animals
30. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder
    Thomas G. Adams, Michael H. Bloch, Christopher Pittenger · 2017 · Journal of Clinical Psychopharmacology
31. The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
    Ranjana Bhandari, Japneet Kaur, Simerpreet Kaur, Anurag Kuhad · 2021 · Expert Opinion on Therapeutic Targets
32. Obsessive-Compulsive Disorder, PANDAS, and Tourette Syndrome: Immuno-inflammatory Disorders
    Donatella Marazziti, Stefania Palermo, Alessandro Arone, Lucia Massa, Elisabetta Parra, Marly Simoncini, Lucía Martucci, Maria Francesca Beatino, Andrea Pozza · 2023 · Advances in experimental medicine and biology
33. Lower Posterior Cingulate Cortex Glutathione Levels in Obsessive-Compulsive Disorder
    Brian P. Brennan, John Eric Jensen, Chris Perriello, Harrison Graham Pope, Michael A. Jenike, James I. Hudson, Scott L. Rauch, Marc J. Kaufman · 2015 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
34. Striatal structure and its association with N-Acetylaspartate and glutamate in autism spectrum disorder and obsessive compulsive disorder
    Jilly Naaijen, Marcel P. Zwiers, Natalie J. Forde, Steven Williams, Sarah Durston, Daniel Brandeis, Jeffrey Colm Glennon, Barbara Franke, David J. Lythgoe, Jan K. Buitelaar · 2017 · European Neuropsychopharmacology
35. Neuroimaging Studies in Obsessive Compulsive Disorder: A Narrative Review
    Arpit Parmar, Siddharth Sarkar · 2016 · Indian Journal of Psychological Medicine
36. Lower Ventromedial Prefrontal Cortex Glutamate Levels in Patients With Obsessive–Compulsive Disorder
    Marcelo C. Batistuzzo, Bruna A. Sottili, Roseli Gedanke Shavitt, Antônio Carlos Lopes, Carolina Cappi, Maria Alice de Mathis, Bruno Pastorello, Juliana Belo Diniz, Renata M.F. Silva, Eurı́pedes Constantino Miguel et al. · 2021 · Frontiers in Psychiatry
37. Monitoring glutamate levels in the posterior cingulate cortex of thyroid dysfunction patients with TE-averaged PRESS at 3T
    Qiujuan Zhang, Zhi-lan Bai, Yan Gong, Xinxin Liu, Xiao-Qing Dai, Shejiao Wang, Feng Liu · 2015 · Magnetic Resonance Imaging
38. Excessive habit formation in schedule‐induced polydipsia: Microstructural analysis of licking among rat strains and involvement of the orbitofrontal cortex
    Ana Merchán, Santiago Mora, Belén Gago, Elisa Rodríguez‐Ortega, Alberto Fernández‐Teruel, Jorge López Puga, Fernando Sánchez-Santed, Margarita Moreno, Pilar Flores · 2018 · Genes Brain & Behavior
39. Genetic susceptibility in obsessive-compulsive disorder
    Thomas V. Fernandez, James Frederick Leckman, Christopher Pittenger · 2018 · Handbook of clinical neurology
40. Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder
    Sean C. Piantadosi, Lora Lee McClain, Lambertus Klei, Jiebiao Wang, Brittany L. Chamberlain, Sara A. Springer, David A. Lewis, Bernie Devlin, Susanne E. Ahmari · 2021 · Translational Psychiatry
41. The BDNF Val66Met polymorphism enhances glutamatergic transmission but diminishes activity-dependent synaptic plasticity in the dorsolateral striatum
    Deqiang Jing, Francis S. Lee, Ipe Ninan · 2016 · Neuropharmacology
42. White matter microstructural abnormalities and gray matter volume alterations in obsessive-compulsive disorder: A coordinate-based meta-analysis
    Qiuying Tao, Jinghan Dang, Xiaoyu Niu, Xinyu Gao, Mengzhe Zhang, Zhengui Yang, Yinhuan Xu, Miaomiao Yu, Jingliang Cheng, Shaoqiang Han et al. · 2022 · Journal of Affective Disorders
43. Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications
    Szmulewicz, Alejandro, Samamé, Cecilia, Caravotta, Pablo, Martino, Diego J., Igoa, Ana, Hidalgo-Mazzei, Diego, Colom, Francesc, Strejilevich, Sergio A. · 2016 · International Journal of Bipolar Disorders
44. Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial
    Sahraian, Ali, Bigdeli, Mohammad, Ghanizadeh, Ahmad, Akhondzadeh, Shahin · 2014 · Journal of Affective Disorders
45. Lateral orbitofrontal dysfunction in the Sapap3 knockout mouse model of obsessive–compulsive disorder
    Huimeng Lei, Juan Lai, Xiaohong Sun, Qunyuan Xu, Guoping Feng · 2019 · Journal of Psychiatry and Neuroscience
46. l -Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Alireza Ghajar, Farinaz Aghajan-Nashtaei, Mohsen Afarideh, Mohammad-Reza Mohammadi, Shahin Akhondzadeh · 2018 · Journal of Child and Adolescent Psychopharmacology
47. Psilocybin for the Treatment of Obsessive-Compulsive Disorders
    Katja Ehrmann, John J. B. Allen, Francisco Moreno · 2021 · Current topics in behavioral neurosciences
48. The need for inclusion of sex and age of onset variables in genetic association studies of obsessive–compulsive disorder: Overview
    Gabriella Francesca Mattina, Meir S Steiner · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
49. Back to the Future: Circuit-testing TS & OCD
    Frank H. Burton · 2017 · Journal of Neuroscience Methods
50. The Pharmacological Treatment of Obsessive-Compulsive Disorder
    Christopher Pittenger · 2023 · Psychiatric Clinics of North America
51. Increased Fear Memory and Glutamatergic Modulation in Compulsive Drinker Rats Selected by Schedule-Induced Polydipsia
    Ángeles Prados-Pardo, Elena Martín-González, Santiago Mora, Ana Merchán, Pilar Flores, Margarita Moreno · 2019 · Frontiers in Behavioral Neuroscience
52. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy
    Helen Blair Simpson, Lawrence S. Kegeles, Liane E. Hunter, Xiangling Mao, Page E. Van Meter, Xiaoyan Xu, Marcia B. Kimeldorf, Sarah L. Pearlstein, Mark Slifstein, Dikoma C. Shungu · 2015 · Psychiatry Research Neuroimaging
53. Catechol-O-Methyltransferase Gene Polymorphisms in Specific Obsessive–Compulsive Disorder Patients’ Subgroups
    Fernanda Brito Melo-Felippe, Juliana Braga de Salles Andrade, Isabele Gomes Giori, Tamiris Vieira-Fonseca, Leonardo Franklin Fontenelle, Fabiana B. Kohlrausch · 2015 · Journal of Molecular Neuroscience
54. Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control
    Sina Naderi, Heidar Faghih, Ali Aqamolaei, Seyyed Hosein Mortazavi, Amirhosein Mortezaei, Erfan Sahebolzamani, Farzin Rezaei, Shahin Akhondzadeh · 2018 · Psychiatry and Clinical Neurosciences
55. Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms
    Helen M Collins · 2024 · The International Journal of Neuropsychopharmacology
56. Astrocyte Dysfunctions in Obsessive Compulsive Disorder: Rethinking Neurobiology and Therapeutic Targets
    Laurine Gonzalez, Paola Bezzi · 2025 · Journal of Neurochemistry
57. Inflammation, Obsessive-Compulsive Disorder, and Related Disorders
    Jeffrey H. Meyer · 2021 · Current topics in behavioral neurosciences
58. Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-traumatic brain injury anxiety and social impairment
    Dmitry Frank, B. Gruenbaum, I. Shelef, V. Zvenigorodsky, O. Severynovska, I. Fleidervish, Boris Knyazer, A. Frenkel, A. Zlotnik, O. Kofman et al. · 2023 · Translational Psychiatry
59. Glutamatergic augmentation strategies in obsessive–compulsive disorder
    JanardhananC Narayanaswamy, Karthik Sheshachala · 2019 · Indian Journal of Psychiatry
60. Brain areas involved with obsessive-compulsive disorder present different DNA methylation modulation
    Kátia Cristina de Oliveira, Caroline Camilo, Vinícius Daguano Gastaldi, Arthur Sant’Anna Feltrin, Bianca Cristina Garcia Lisbôa, Vanessa de Jesus Rodrigues de Paula, Ariane Cristine Moretto, Beny Lafer, Marcelo Q. Hoexter, Eurı́pedes Constantino Miguel et al. · 2021 · BMC Genomic Data
61. Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD: An Integrated Multimodal fMRI/1H MRS Study
    Reza Tadayonnejad, D. Rangaprakash, Olusola Ajilore, Teena D. Moody, Francesca Morfini, Ronald Ly, Joseph O’Neill, Jamie D. Feusner · 2017 · Neuropsychopharmacology
62. Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder
    Christopher Pittenger, Brian P. Brennan, Lorrin M. Koran, Carol A. Mathews, Gerald Nestadt, Michele T. Pato, Katharine A. Phillips, Carolyn I. Rodríguez, Helen Blair Simpson, Petros Skapinakis et al. · 2021 · Psychiatry Research
63. Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
    Manuel Arrojo, María Tajes Alonso, José de León · 2013 · Case Reports in Psychiatry
64. A Theoretical Study on the Role of Astrocytic Activity in Neuronal Hyperexcitability by a Novel Neuron-Glia Mass Model
    Aurélie Garnier, Alexandre Campane Vidal, Habib Benali · 2016 · The Journal of Mathematical Neuroscience
65. Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial.
    Sophia Esalatmanesh, Mojtaba Biuseh, Ahmad Ali Noorbala, Seyed‐Ali Mostafavi, Farzin Rezaei, Bita Mesgarpour, Payam Mohammadinejad, Shahin Akhondzadeh · 2017 · Europe PMC (PubMed Central)
66. Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature
    Konstantin Mechler, Alexander Häge, Nina Schweinfurth, Jeffrey Colm Glennon, Rick M. Dijkhuizen, Declan Murphy, Sarah Durston, Steven Williams, Jan K. Buitelaar, Tobias Banaschewski et al. · 2017 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
67. Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behaviours
    Carey Wilson, James J Gattuso, Anthony John Hannan, Thibault Renoir · 2023 · Neurobiology of Disease
68. Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive–compulsive disorder
    Eva Real, Mónica Gratacòs, Javier Labad, Pino Alonso, Geòrgia Escaramís, Cinto Segalàs, Marta Subirà, Clara López‐Solà, Xavier Estivill, José Manuel Menchón · 2012 · The Pharmacogenomics Journal
69. N-acetylcysteine augmentation in treatment resistant obsessive compulsive disorder: A case series
    M. V. van Ameringen, B. Patterson, W. Simpson, J. Turna · 2013 · Journal of Obsessive-Compulsive and Related Disorders
70. Common abnormality of gray matter integrity in substance use disorder and obsessive‐compulsive disorder: A comparative voxel‐based meta‐analysis
    Benjamin Klugah‐Brown, Chenyang Jiang, Elijah Agoalikum, Xinqi Zhou, Liye Zou, Qian Yu, Benjamin Becker, Bharat B. Biswal · 2021 · Human Brain Mapping
71. Challenges in the diagnosis and treatment of pediatric obsessive–compulsive disorder
    S. Evelyn Stewart, Clara Y. Westwell-Roper · 2019 · Indian Journal of Psychiatry
72. N-Acetylcysteine Augmentation in Children and Adolescents Diagnosed With Treatment-Resistant Obsessive-Compulsive Disorder: Case Series.
    K. Yazıcı, İ. Perçinel · 2015 · Journal of Clinical Psychopharmacology
73. Study of symptom dimensions and clinical characteristics in Chinese patients with OCD
    Xinhua Zhang, Jie Liu, Jiajia Cui, Chuanqin Liu · 2013 · Journal of Affective Disorders
74. Auto-Reactive Th17-Cells Trigger Obsessive-Compulsive-Disorder Like Behavior in Mice With Experimental Autoimmune Encephalomyelitis
    Ravi Kant, Shweta Pasi, Avadhesha Surolia · 2018 · Frontiers in Immunology
75. The Glutamate and the Immune Systems: New Targets for the Pharmacological Treatment of OCD
    Donatella Marazziti, Umberto Albert, Federico Mucci, Armando Piccinni · 2018 · Current Medicinal Chemistry
76. Mitochondrial Dysfunction as a Key Event during Aging: From Synaptic Failure to Memory Loss
    Claudia Jara, Angie K. Torres, Margrethe A. Olesen, Cheril Tapia‐Rojas · 2019 · IntechOpen eBooks
77. 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control
    Farzaneh Yousefzadeh, Erfan Sahebolzamani, Arash Sadri, Amirhosein Mortezaei, Ali Aqamolaei, Seyyed Hosein Mortazavi, Mohammadreza Shalbafan, Salomeh Ghaffari, Rosa Alikhani, Seiedeh Bentolhoda Mousavi et al. · 2020 · International Clinical Psychopharmacology
78. A closer look to neural pathways and psychopharmacology of obsessive compulsive disorder
    Gargano, Steven P., Santos, Melody G., Taylor, Sydney M., Pastis, Irene · 2023 · Frontiers in Behavioral Neuroscience
79. Management of obsessive-compulsive disorder comorbid with bipolar disorder
    Firoz Kazhungil, Edakkunni Mohandas · 2016 · Indian Journal of Psychiatry
80. Disruption of Ninjurin1 Leads to Repetitive and Anxiety-Like Behaviors in Mice
    Hoang Le, Bum Ju Ahn, Hye Shin Lee, Anna Shin, Sujin Chae, Sung Yi Lee, Min Wook Shin, Eun-Ji Lee, Jong‐Ho Cha, Taekwon Son et al. · 2016 · Molecular Neurobiology
81. S-ketamine reduces marble burying behaviour: Involvement of ventromedial orbitofrontal cortex and AMPA receptors
    Cristina Luz Tosta, Gabriela Pandini Silote, Maria Paula dos Santos Fracalossi, Ariandra Guerini Sartim, Roberto Andreatini, Sâmia R.L. Joca, Vanessa Beijamini · 2018 · Neuropharmacology
82. Reduced anterior cingulate glutamate of comorbid skin-picking disorder in adults with obsessive-compulsive disorder
    Huirong Zheng, Wanqun Yang, Bin Zhang, Guanmin Hua, Shibin Wang, Fu‐Jun Jia, Guangquan Guo, Wenjing Wang, Dongming Quan · 2020 · Journal of Affective Disorders
83. Lmx1b is required for the glutamatergic fates of a subset of spinal cord neurons
    William C. Hilinski, Jonathan R. Bostrom, Samantha J. England, José L. Juárez‐Morales, Sarah de Jager, Olivier Armant, Jessica Legradi, Uwe Strähle, Brian A. Link, Katharine E. Lewis · 2016 · Neural Development
84. Altered serotonergic and GABAergic neurotransmission in a mice model of obsessive-compulsive disorder
    Christine Winter, Dana M. Greene, Paraskevi Mavrogiorgou, Helge Ascan Schaper, Reinhard Sohr, Abel Bult‐Ito, Georg Juckel · 2017 · Behavioural Brain Research
85. The roles of neuroinflammation and glutamatergic excitotoxicity in treatment-resistant depression
    Ryan Candee, Rachel Wilkenson, M. Schreiber, M. Decenzo · 2023 · JAAPA : official journal of the American Academy of Physician Assistants
86. Effects of lipophilic phycotoxin okadaic acid on the early development and transcriptional expression of marine medaka Oryzias melastigma
    Yongmeng Yang, Aifeng Li, Jiangbing Qiu, Wenhui Yan, Lilin Han, Dongyue Li, Chao Yin · 2023 · Aquatic Toxicology
87. Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit/hyperactivity disorder and functional exploration of risk loci
    Qi Zhang, Xinzhen Chen, Shanyawen Li, Ting Yao, Jing Wu · 2020 · Journal of Psychiatric Research
88. Distinct associations between fronto-striatal glutamate concentrations and callous-unemotional traits and proactive aggression in disruptive behavior
    Michael Craig, Leandra M. Mulder, Marcel P. Zwiers, Arjun Sethi, Pieter J. Hoekstra, Andrea Dietrich, Sarah Baumeister, Pascal-M. Aggensteiner, Tobias Banaschewski, Daniel Brandeis et al. · 2019 · Cortex
89. Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid
    Dominique Endres, Benjamin Pankratz, Tilman Robinson, Karoline Pitsch, Theresa Göbel, Kimon Runge, Andrea Schlump, Kathrin Nickel, Marco Reisert, Horst Urbach et al. · 2022 · Molecular Psychiatry
90. The development of compulsive coping behaviour is associated with a downregulation of Arc in a Locus Coeruleus neuronal ensemble
    Clara Velázquez-Sánchez, Leila Mureşan, Lucía Martí‐Prats, David Belin · 2023 · Neuropsychopharmacology
91. The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
    Matteo Marcatili, Cristian Pellicioli, Laura Maggioni, Federico Luigi Motta, Redaelli Chiara, Ghelfi Lorenzo, Krivosova Michaela, Matteo Sibilla, Roberto Nava, Fabrizia Colmegna et al. · 2021 · Annals of General Psychiatry
92. The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
    Licia Vellucci, Mariateresa Ciccarelli, Elisabetta Filomena Buonaguro, Michele Fornaro, Giordano D’Urso, Giuseppe De Simone, Felice Iasevoli, Annarita Barone, Andrea de Bartolomeis · 2023 · Biomolecules
93. Factors associated with obsessive–compulsive symptoms in people with epilepsy
    Soo Jeong Kim, Sang‐Ahm Lee, Han Uk Ryu, Su‐Hyun Han, Gha-hyun Lee, Kwang-Deog Jo, Jung Bin Kim · 2019 · Epilepsy & Behavior
94. Little evidence for neurometabolite alterations in obsessive-compulsive disorder - A systematic review of magnetic resonance spectroscopy studies at 3 Tesla
    Eline L. Vester, Niels T. de Joode, Chris Vriend, Petra J. W. Pouwels, Odile A. van den Heuvel · 2020 · Journal of Obsessive-Compulsive and Related Disorders
95. Synaptic reshaping of plastic neuronal networks by periodic multichannel stimulation with single-pulse and burst stimuli
    Justus A. Kromer, Peter Alexander Tass · 2022 · PLoS Computational Biology
96. Changes of motor cortical excitability and response inhibition in patients with obsessive–compulsive disorder
    Jee In Kang, Deog Young Kim, Chang-il Lee, Chan‐Hyung Kim, Se Joo Kim · 2019 · Journal of Psychiatry and Neuroscience
97. Neurochemical correlates of behavioral treatment of pediatric trichotillomania
    Tara S. Peris, John C. Piacentini, Allison Vreeland, Giulia C. Salgari, Jennifer G. Levitt, Jeffrey Alger, Stefan Posse, James T. McCracken, Joseph O’Neill · 2020 · Journal of Affective Disorders
98. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive–compulsive disorder
    Maria Ljungberg, Marie K. L. Nilsson, Karin Melin, Lars Jönsson, Arvid Carlsson, Åsa Carlsson, Eva B. Forssell-Aronsson, Tord Ivarsson, Maria Lizzie Carlsson, Göran Starck · 2016 · Acta Neuropsychiatrica
99. Appetitive Needs and Addiction
    Steve Y. Sussman, Sheila Pakdaman · 2020 · Cambridge University Press eBooks
100. A biophysical model for dopamine modulating working memory through reward system in obsessive–compulsive disorder
     Lining Yin, Fang Han, Qingyun Wang · 2023 · Cognitive Neurodynamics